Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers - Wikidata - awgldk - TriplyDB

Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers

Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers

http://www.wikidata.org/entity/Q41114632

about

Cerebrospinal fluid biomarkers of Alzheimer’s disease Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.Gaps in Aging Research as it Applies to Rheumatologic Clinical Care.History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.Multimarker screening of oxidative stress in aging.Obesity, age, and oxidative stress in middle-aged and older women.Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.Oxidative Stress and Its Clinical Applications in Dementia Ambient air pollution and neurotoxicity on brain structure: Evidence from women's health initiative memory study Unusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidations Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.Markers of oxidant stress that are clinically relevant in aging and age-related disease The association of serum trans-nonachlor levels with atherosclerosis.Age-Related Decrease in Heat Shock 70-kDa Protein 8 in Cerebrospinal Fluid Is Associated with Increased Oxidative Stress Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies.Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects.The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging.

P2860

Q22252572-74742703-C256-4E15-9835-2777E6F6109C Q24595802-7C5442B9-1897-475A-9979-779FBB478CBA Q26864770-F82499FD-CF48-44EB-83B6-60F20389919D Q30052936-20DBF48E-242C-49E4-8FFF-6874F3EC6B72 Q30240678-72629848-2E97-4B4C-80AD-D85F6E289585 Q33462295-3EB36B6D-FFB0-447F-B109-FB0825A361A3 Q34014251-36C7557C-0F25-4AC8-AFC5-FAB9B9DB67AA Q34987129-B21B8977-60F7-4E82-8C67-12617E72AF16 Q35143061-F5E37F3E-9C07-4339-A04F-3CFE274F9416 Q35542811-31ED1BEA-6186-4CF4-A58C-6A72A091F616 Q35623258-43083758-B349-49FD-902C-8159EC753358 Q35987458-55839022-3874-41C7-BC17-ABF8A1B25F64 Q36082929-85D4C716-650A-4D8B-82EF-CEA5EA89CA9E Q36094027-C486E908-DCDC-4E66-B72E-73E8D43BD1AE Q36879018-9F74071D-946A-4C38-9457-77677C7A9CAF Q36992739-154EE9E5-503E-493D-A259-16DFEAE4E4E9 Q37124348-692EAB78-8E7E-4827-BC6E-3B5324DA206E Q37524486-5B5BF6CF-3A8E-4BB6-B42A-F9E345A9E4EC Q38836837-7205BD80-C7A0-42A7-8506-1B183D8F7015 Q48541060-FE9A7AC1-2150-447C-B88D-287CB0D436BB Q52373518-7A4066F0-E2F2-441B-881C-84164AF3B757 Q52595131-F2807954-5400-406B-93FE-53385BEF02F2 Q54878401-7A605317-A75C-48AB-9F4B-1F8A905C85F1

P2860

Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers

http://www.wikidata.org/entity/Q41114632

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Increased cerebrospinal fluid ...... se as identified by biomarkers

@en

type

label

Increased cerebrospinal fluid ...... se as identified by biomarkers

@en

prefLabel

Increased cerebrospinal fluid ...... se as identified by biomarkers

@en

P1433

Q41114632-589AEF15-782F-47D3-AEE2-613F1C5FE177

P1476

Q41114632-F338414C-E45A-4F86-BC27-5027CA82EC54

P2093

Q41114632-2AF316B7-D7DC-4115-8C18-8D11FADD46DD

Q41114632-48B5E7E0-C046-474D-8FC2-1B9E9FC6AE96

Q41114632-5464279D-E671-43E6-AA22-9D81EE70BEF1

Q41114632-7770C7ED-13DE-472D-AFA4-F5CE6D519A4A

Q41114632-C075FE93-57D6-4537-A1B8-73FD1B61EEDC

P2860

Q41114632-016E732E-EC23-4247-AC51-91A804C52931

Q41114632-01A55CCD-0D2E-4933-A417-D10625D6647F

Q41114632-06C41014-29C1-4186-8929-1B30B2898C64

Q41114632-192CBB67-5CFE-4226-AF94-102AE41AE35A

Q41114632-1A0BA586-CE0C-4D46-8FA3-CF7B45C25A06

Q41114632-1ACC38EF-61DD-4065-A115-7A83736CAA5D

Q41114632-1F4C3550-E933-4E82-96D8-20D2A767D592

Q41114632-22D0052C-EA92-4E62-A46F-05995A9CA524

Q41114632-2BBAD46D-5A5B-443E-AF7B-6C8F618A235A

Q41114632-2E004832-FFF0-4BEC-8368-B8C135368F5B

P2888

Q41114632-B1E02179-28E4-44B2-9F52-91812FBA31E9

P304

Q41114632-D5187E5F-A383-4757-A9B5-293ADFB4769C

P31

Q41114632-23820609-98CC-4469-83B9-A4A4AF005E7E

P356

Q41114632-F744E496-0B20-40EE-894A-7A000C5008F4

P433

Q41114632-8FA767D0-B60D-450E-96B6-560D281E1D40

P478

Q41114632-C1656183-CE60-4EF0-A6AD-72F890088ACC

P50

Q41114632-45AFF2C8-17DA-420A-B50D-75FCC943301B

P577

Q41114632-0012DE55-5F46-4666-8EE6-8A96E34C21FD

P5875

Q41114632-D4BA825D-24C3-4F66-BE60-4114138FCF28

P698

Q41114632-7CFDEB28-6CAD-47B6-9493-261197C863F8

P921

Q41114632-012D1C43-5FCF-4333-A280-085E3DDDAC56

Q41114632-36C2C34F-0702-48AC-89D9-7731BCCA40FD

Q41114632-571C5D82-B81F-4D0C-AB88-17314A643FF7

Q41114632-844E7142-E6E5-46F2-BBF2-316FAC7FE2D6

P932

Q41114632-20FABA49-842D-402E-AC96-66344BDA24E6

P356

S12017-010-8126-6

P1433

NeuroMolecular Medicine

P1476

Increased cerebrospinal fluid ...... se as identified by biomarkers

@en

P2093

Angela M Wilson

http://www.w3.org/2001/XMLSchema#string

Douglas Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Kathleen S Montine

http://www.w3.org/2001/XMLSchema#string

Thomas J Montine

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

Biomarkers for cognitive impairment and dementia in elderly people.

Mild cognitive impairment: an overview.

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

Cognition, reserve, and amyloid deposition in normal aging.

Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease.

F2-isoprostanes in Alzheimer and other neurodegenerative diseases.

Healthy ageing in the Nun Study: definition and neuropathologic correlates.

P2888

s12017-010-8126-6

P304

37-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12017-010-8126-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45189357

http://www.w3.org/2001/XMLSchema#string

P698

20632131

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

3000441

http://www.w3.org/2001/XMLSchema#string